Just one week until SMi's 2nd Annual AI in Drug Delivery Virtual Conference

LONDON - March 8, 2021 - PRLog -- There is just one week to go until SMi's 2nd Annual AI in Drug Delivery Conference which will convene virtually on the 15th and 16th March 2021.

It is crucial for scientific researchers to stay on top of the latest advancements, technologies and processes related to artificial intelligence in drug discovery, this conference has gathered experts representing to share their key insights at the virtual conference.

With 1 week to go and registration closes soon, interested parties can register at £999 for vendors, £499 for pharmaceutical firms on http://www.ai-indrugdiscovery.com/pr5 (http://www.ai-indrugdiscovery.com/PJpr5).

SMi Group welcome the sponsors of the conference, CAS, Dassault Systèmes & Gero. All sponsors will be exhibiting at the virtual conference where they will showcase their latest products and solutions to the industry's ongoing challenges. Speaking over the two-day event:

Day One - Combining Machine learning and Molecular Modelling for enhanced Active learning in small-Molecule Drug Design
Presented by Ton van Daelen, BIOVIA Life Sciences Portfolio Director at Dassault Systèmes and Scott Bembenek, Founder, CEO, CSO, Denovicon Therapeutics.

Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine sustainable innovations.

Day Two - Discover New Chemistry with more Efficient Exploration of Chemical Space
Presented by Yugal Sharma, Senior Director, Services at CAS.

CAS, a division of the American Chemical Society, specializes in scientific information solutions to help R&D organizations globally plan, innovate, and protect their innovations, and predict how new markets and opportunities will evolve.

Day Two - How does AI help to utilize Genetic, Transcriptomic And Clinical Data for Target Identification in Complex Diseases?
Presented by Peter Fedichev, CEO and Founder at Gero.ai

Gero is the next-gen AI drug discovery company utilizing real-world big clinical, genetic (WES), and molecular data from vast human cohorts instead of animal models to help their partners create revolutionary medicines against complex diseases.

The full speaker line up, brochure and agenda is available at http://www.ai-indrugdiscovery.com/PJpr5 (http://www.ai-indrugdiscovery.com/pr5)

Sponsored by: CAS, Dassault Systems and Gero
Parties interested in sponsoring, exhibiting or speaking at this event can contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

SMi's 2nd Annual AI in Drug Discovery Conference
Conference: 15 – 16 March 2021
Virtual Conference: Online Access Only
http://www.ai-indrugdiscovery.com/pr5
#SMiAIinDrugDis